Researchers developed a diagnostic test based on the LIMA1-alpha protein to distinguish patients with head and neck squamous cell carcinoma who can be cured with surgery alone, without the need for ...

Researchers from the University of Turku and Turku University Hospital, Finland, led by Docent Sami Ventelä and Professor ...

Esophageal squamous cell carcinoma (ESCC) is a deadly cancer with particularly high prevalence in East Asia. While ...

Talking to loved ones about a recent head and neck cancer diagnosis can be overwhelming. Of course, there is no one "right" ...

Head and neck cancers arise in the nasal cavity, sinuses, lips, mouth, salivary glands, throat or larynx. As per the National ...

Locally advanced (generally stage 3) head and neck squamous cell carcinoma is cancer that has grown outside its original location but has not yet spread to distant sites. It can be challenging to ...

Resectable locally advanced head and neck squamous-cell carcinoma (HNSCC) is a burdensome disease with few treatment advances in recent decades.

Neo-adjuvant nivolumab or nivolumab with ipilimumab in advanced cutaneous squamous cell carcinoma prior to surgery. ClinicalTrials.gov. Updated October 26, 2022.

C5aR1 has previously been found to be upregulated in several inflammatory and infectious diseases, as well as in cancer types like non-small cell lung cancer and gastric cancer.

Regeneron Pharmaceuticals announced promising results from the Phase 3 C-POST trial of Libtayo (cemiplimab), a PD-1 inhibitor for patients with high-risk cutaneous squamous cell carcinoma (CSCC ...

KEYWORDS: Squamous Cell Carcinoma, NUT Carcinoma, Nose, Lymph Node Dissection, Radiotherapy JOURNAL NAME: Surgical Science, Vol.16 No.5, May 31, 2025 ABSTRACT: Introduction: NUT carcinoma is a highly ...

Patients who have cutaneous squamous-cell carcinoma with high-risk features are at risk for recurrence after definitive local therapy. The benefit of systemic adjuvant therapy options has not been ...